In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
August 19th, 2011 | 24 | Yes |
Popular Name: N-cyclohexyl-6-(1H-indazol-5-yl)imidazo[2,1-b]thiazol-5-amine N-cyclohexyl-6-(1H-indazol-5-yl)…
None
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 4.26 | 9.59 | -11.69 | 2 | 5 | 0 | 58 | 337.452 | 3 | ↓ |
Lo Low (pH 4.5-6) | 4.26 | 9.8 | -43.85 | 3 | 5 | 1 | 63 | 338.46 | 3 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
GSK3B-1-E | Glycogen Synthase Kinase-3 Beta (cluster #1 Of 7), Eukaryotic | Eukaryotes | 642 | 0.36 | Binding ≤ 10μM |
PIM1-1-E | Serine/threonine-protein Kinase PIM1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1292 | 0.34 | Binding ≤ 10μM |
ROCK2-1-E | Rho-associated Protein Kinase 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 622 | 0.36 | Binding ≤ 10μM |
VGFR2-1-E | Vascular Endothelial Growth Factor Receptor 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 5339 | 0.31 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 642 | 0.36 | Binding ≤ 1μM |
ROCK2_HUMAN | O75116 | Rho-associated Protein Kinase 2, Human | 622 | 0.36 | Binding ≤ 1μM |
GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 642 | 0.36 | Binding ≤ 10μM |
ROCK2_HUMAN | O75116 | Rho-associated Protein Kinase 2, Human | 622 | 0.36 | Binding ≤ 10μM |
PIM1_HUMAN | P11309 | Serine/threonine-protein Kinase PIM1, Human | 1292 | 0.34 | Binding ≤ 10μM |
VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 5339 | 0.31 | Binding ≤ 10μM |
Description | Species |
---|---|
AKT phosphorylates targets in the cytosol | |
APC truncation mutants have impaired AXIN binding | |
AXIN missense mutants destabilize the destruction complex | |
Beta-catenin phosphorylation cascade | |
Constitutive PI3K/AKT Signaling in Cancer | |
CRMPs in Sema3A signaling | |
Degradation of beta-catenin by the destruction complex | |
disassembly of the destruction complex and recruitment of AXIN to the membrane | |
EPHA-mediated growth cone collapse | |
EPHB-mediated forward signaling | |
G alpha (12/13) signalling events | |
Integrin cell surface interactions | |
misspliced GSK3beta mutants stabilize beta-catenin | |
Neurophilin interactions with VEGF and VEGFR | |
Regulation of HSF1-mediated heat shock response | |
S33 mutants of beta-catenin aren't phosphorylated | |
S37 mutants of beta-catenin aren't phosphorylated | |
S45 mutants of beta-catenin aren't phosphorylated | |
Sema4D induced cell migration and growth-cone collapse | |
T41 mutants of beta-catenin aren't phosphorylated | |
truncations of AMER1 destabilize the destruction complex | |
VEGF binds to VEGFR leading to receptor dimerization | |
VEGFA-VEGFR2 Pathway | |
VEGFR2 mediated cell proliferation |
No pre-computed analogs available. Try a structural similarity search.